Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases

Details for Australian Patent Application No. 2003234626 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003234626

PCT Number PCT/US03/15470

PCT Pub. Number WO2003/097052

Priority 60/380,842 17.05.02 US; 60/424,600 06.11.02 US

Filing date 16 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 9 March 2006

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/380,842 17.05.02 US; 60/424,600 06.11.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003234626

9 March 2006 Application Accepted

  Published as AU-B-2003234626

20 July 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 26 Jun 2006. Address for service in Australia - Phillips Ormonde & Fitzpatrick Levels 21 & 22 367 Collins Street MELBOURNE VIC 3000

8 February 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 26 Jun 2006

8 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003234627-THROUGH THE HOLE ROTARY POSITION SENSOR

2003234625-Methods and copositions for the treatment of ischemic reperfusion